Biostar Pharmaceuticals, Inc. (BSPM)

[Michael Anderson]

I know, I was just showing examples of how undervalued the stock is regardless of dilution. So I was not being overly specific as to when. I personally say 15 P/E(not that I think it will) because of the growth potential over the next few years, 10-12 p/e is a better for the price point and it will depend on 2011 guidance as well. With SGA spending so high even if there was 0% sales growth for 2011 based on my estimates, but they were able to get SGA/revenue down to 35%, then that would give net income of over 30 million. For the short term stock price I am not to sure on how EPS will come in for q2, hard to tell. For me for the 2nd quarter I am more concerned about sales and then I think q3 and q4 will be a blow out quarters: several new products, Xian Meipude, raw materials, expansion to other areas getting in full swing on top of the other growth.